The global Mobile C-Arms Market will be worth USD 1.61 billion by 2027, according to a
current analysis by Emergen Research. The increasing emergence of chronic
diseases over the recent past that need early assessment and on-time diagnosis
for prevention of complications is mainly stimulating the growth of the market.
Moreover, the growing number of road accidents which often leads to orthopedic
injuries are fueling the demand for all kinds of mobile c-arm devices.
Additionally, the rise in geriatric population, advancements in technology
across various regions as well as the rising inclination towards minimally
invasive surgical procedures are also stimulating the market growth.
Key Highlights From The
Report.
In January 2020,
Trivitron Healthcare launched digital c-arm named Elite at Arab Health 2020
conference in Dubai. Elite helps to deliver high quality images with better
greyscale resolution in order to find out minute details as well as increase
operational efficiency by accurately positioning movements.
The full-size c-arm
devices segment held the most prominent market share in because of the increase
in the area of application particularly across surgical and orthopedic
procedures. The technology makes it painless for patients as well as increases
the ease of diagnosis for healthcare professionals.
When it comes to the
application areas, orthopedics and trauma segment accounted for the largest
market share because incorporation of mobile c-arms has reduced operational
risks and increased efficiency. Moreover, usage of these devices has also
increased affordability associated with radiography..
Key participants include Toshiba Medical Systems, Philips
Healthcare, GE Healthcare; Hologic Corporation; Shimadzu Corporation, Siemens
AG, Ziehm Imaging, Eurocolumbus s.r.l., OrthoScan, Inc. and Hitachi Medical
Systems among others.
Request
for sample report@ https://www.emergenresearch.com/request-sample/309
Type Outlook (Revenue, USD Billion; 2017-2027)
Full-Size
C-Arms
Mini
C-Arms
Application Type Outlook (Revenue, USD Billion;
2017-2027)
Orthopedics
and Trauma
Neurology
Cardiology
Pain
Management
Gastroenterology
Oncology
Regional Outlook (Revenue, USD Billion;
2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
No comments:
Post a Comment